Skip to main content

Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ: MRVI · IEX Real-Time Price · USD
41.30
-0.70 (-1.67%)
After-hours:Oct 22, 2021 6:32 PM EDT
42.00
-0.23 (-0.54%)
At close: Oct 22, 4:00 PM
Market Cap5.44B
Revenue (ttm)552.20M
Net Income (ttm)n/a
Shares Out112.20M
EPS (ttm)4.12
PE Ratio10.19
Forward PE29.07
Dividendn/a
Ex-Dividend Daten/a
Volume1,698,661
Open42.42
Previous Close42.23
Day's Range41.35 - 42.61
52-Week Range23.62 - 63.55
Betan/a
AnalystsStrong Buy
Price Target58.25 (+38.7%)
Est. Earnings DateNov 10, 2021

About MRVI

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of var...

IndustryBiotechnology
IPO DateNov 20, 2020
Employees490
Stock ExchangeNASDAQ
Ticker SymbolMRVI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for MRVI stock is "Strong Buy." The 12-month stock price forecast is 58.25, which is an increase of 38.69% from the latest price.

Price Target
$58.25
(38.69% upside)
Analyst Consensus: Strong Buy

News

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021

SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to ...

1 week ago - GlobeNewsWire

New Strong Buy Stocks for October 8th

CNXC, DLTH, NVEE, MRVI, and PFSI have been added to the Zacks Rank #1 (Strong Buy) List on October 8, 2021.

Other symbols:CNXCDLTHNVEEPFSI
2 weeks ago - Zacks Investment Research

Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent

Advancement Expected to Further Accelerate Development of mRNA Vaccines and Therapeutics Advancement Expected to Further Accelerate Development of mRNA Vaccines and Therapeutics

2 weeks ago - GlobeNewsWire

TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea

EyeGene expected to utilize TriLink's CleanCap® technology and modified UTP manufactured by TriLink in the production of its EG-COVID mRNA COVID-19 vaccine for clinical trials EyeGene expected to utiliz...

2 weeks ago - GlobeNewsWire

3 High-Potential MedTech Stocks With More Than 50% Growth YTD

Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.

Other symbols:DGXOPCHWBAWST
3 weeks ago - Zacks Investment Research

Why Maravai LifeSciences Tumbled Nearly 12% Today

A private equity firm and several peers are cashing out of a pile of shares.

1 month ago - The Motley Fool

Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders

SAN DIEGO, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech inn...

1 month ago - GlobeNewsWire

Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders

SAN DIEGO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech inn...

1 month ago - GlobeNewsWire

Thompson Street Capital Partners Acquires Vector Laboratories

ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced it has acquired Vector Laboratories, the Protein Detection business unit of Marav...

1 month ago - Business Wire

Top Ranked Momentum Stocks to Buy for August 13th

MRVI, DSKE, VRTS, and RMBS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 13, 2021.

Other symbols:DSKERMBSVRTS
2 months ago - Zacks Investment Research

Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance

SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, ...

2 months ago - GlobeNewsWire

TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vacci...

TriLink enables Chula VRC to take its Covid-19 vaccine into a First in Human (FIH) phase 1 clinical trial in Thailand with mRNA manufacturing process development and its proprietary mRNA capping technol...

2 months ago - GlobeNewsWire

Maravai LifeSciences To Host Earnings Conference Call on Tuesday, August 10, 2021

SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to ...

3 months ago - GlobeNewsWire

Child Health in Focus in Face of Delta Strain Threat: 3 Picks

Here are three stocks, BAX, BRBR, and MRVI with a favorable Zacks Rank and huge prospects in child healthcare at present.

Other symbols:ABTBAXBRBR
3 months ago - Zacks Investment Research

4 Safe MedTech Bets Before Delta Strain Disrupts the Market Again

Here are four MedTech stocks, HSIC, BRBR, MRVI and EYE, with favorable Zacks Rank and stellar growth parameters.

Other symbols:ALGNBRBREYEHSICZBH
3 months ago - Zacks Investment Research

5 MedTech Stocks to Gain in 2021 as Base Business Recovers

These five MedTech stocks, EYE, MRVI, SONVY, SARTF and HSIC, all with a favorable Zacks Rank and growth parameters are expected to put up a robust performance in 2021.

Other symbols:ALGNEYEHSICZBH
4 months ago - Zacks Investment Research

Maravai LifeSciences' (MRVI) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Maravai LifeSciences Holdings, Inc. (MRVI).

4 months ago - Zacks Investment Research

Maravai LifeSciences Announces June 2021 Investor Conference Schedule

SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to part...

4 months ago - GlobeNewsWire

Tupperware Brands Corp And Redfin Corp Among Today's Top Shorts

The Dow fell 340 points, while the S&P 500 dipped 1.1%, and the Nasdaq dropped 1.2%. If you're looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the data to give ...

Other symbols:RDFNTUPIRTCXL
5 months ago - Forbes

Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance

SAN DIEGO, May 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai)(NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, to...

5 months ago - GlobeNewsWire

Medical Product Stock Q1 Earnings on May 10: MRVI, TGTX & More

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

Other symbols:NSTGSDCSWAVTGTX
5 months ago - Zacks Investment Research

Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021

SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to part...

5 months ago - GlobeNewsWire

Maravai LifeSciences Holdings, Inc. (MRVI) Upgraded to Buy: What Does It Mean for the Stock?

Maravai LifeSciences Holdings, Inc. (MRVI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

5 months ago - Zacks Investment Research

Stock Market Shrugs Off J&J News; Tesla, New IPO Roblox, Vaccine Play Maravai Flash Buy Signals

Stock market rally shrugs off J&J news; Tesla, new IPO Roblox, vaccine play Maravai flash buy signals. Investor's Business Daily has been helping people invest smarter results by providing exclusive sto...

Other symbols:RBLXTSLA
6 months ago - Investors Business Daily

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021

SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to...

6 months ago - GlobeNewsWire